138 related articles for article (PubMed ID: 6230076)
1. Application of a synthetic serine protease inhibitor in the treatment of DIC.
Kosaki G; Kambayashi J; Imaoka S
Bibl Haematol; 1983; (49):317-27. PubMed ID: 6230076
[No Abstract] [Full Text] [Related]
2. [The effects of FUT-175 (nafamostat mesilate) on blood coagulation and experimental disseminated intravascular coagulation (DIC)].
Koshiyama Y; Kobori A; Ogihara M; Yokomoto Y; Ohtani K; Shimamura K; Iwaki M
Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):313-20. PubMed ID: 3443413
[TBL] [Abstract][Full Text] [Related]
3. [Synthetic protease inhibitors for the treatment of DIC].
Takahashi H
Rinsho Byori; 2011 Feb; Suppl 147():152-8. PubMed ID: 21761764
[No Abstract] [Full Text] [Related]
4. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
Isobe J
Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
[TBL] [Abstract][Full Text] [Related]
5. Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY.
Taenaka N; Shimada Y; Kawai M; Yoshiya I; Kosaki G
Anaesthesia; 1981 Apr; 36(4):389-93. PubMed ID: 6787945
[TBL] [Abstract][Full Text] [Related]
6. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
Aramoto H; Saito H; Shigematsu H; Muto T
Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
[TBL] [Abstract][Full Text] [Related]
7. [Anti DIC therapy].
Yahata M; Sakamoto Y
Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249
[TBL] [Abstract][Full Text] [Related]
8. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of disseminated intravascular coagulation with proteinase inhibitor].
Okamoto K; Takeda S; Ohsato K
Nihon Rinsho; 1991 Sep; 49(9):2130-5. PubMed ID: 1960878
[No Abstract] [Full Text] [Related]
10. [Effects of new protease inhibitor (FUT-175) on experimental DIC].
Denno R; Hasegawa I; Sasaki K; Gotoh Y; Ebata T; Totsuka M; Hayasaka H
Masui; 1984 Feb; 33(2):125-30. PubMed ID: 6716646
[No Abstract] [Full Text] [Related]
11. [Improving effect of the synthetic protease inhibitor E-3123 on experimental DIC in dogs].
Kazama M; Kobayashi K; Tahara C; Miyajima Y; Endo Y; Tanaka H; Nakatani T; Tajimi K
Nihon Yakurigaku Zasshi; 1992 Jul; 100(1):47-58. PubMed ID: 1644370
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of gabexate mesilate against experimental disseminated intravascular coagulation in rats.
Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
Haemostasis; 1983; 13(4):262-7. PubMed ID: 6413308
[TBL] [Abstract][Full Text] [Related]
13. Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?
Nishiyama T; Matsukawa T; Hanaoka K
Crit Care Med; 2000 May; 28(5):1419-22. PubMed ID: 10834689
[TBL] [Abstract][Full Text] [Related]
14. [Protection of endotoxin-induced disseminated intravascular coagulation in rats by gabexate mesilate].
Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):633-40. PubMed ID: 6814144
[No Abstract] [Full Text] [Related]
15. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
Maki M; Terao T; Ikenoue T; Takemura T; Sekiba K; Shirakawa K; Soma H
Gynecol Obstet Invest; 1987; 23(4):230-40. PubMed ID: 3111953
[TBL] [Abstract][Full Text] [Related]
17. [An analysis of disseminated intravascular coagulation by fibrinopeptides].
Gando S; Tedo I
Rinsho Ketsueki; 1988 Dec; 29(12):2250-5. PubMed ID: 3150013
[No Abstract] [Full Text] [Related]
18. Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
Murakawa M; Okamura T; Shibuya T; Harada M; Otsuka T; Niho Y
Ann Hematol; 1992 May; 64(5):249-52. PubMed ID: 1623061
[TBL] [Abstract][Full Text] [Related]
19. FOY: [ethyl P-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitro.
Ohno H; Kosaki G; Kambayashi J; Imaoka S; Hirata F
Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):579-88. PubMed ID: 6449757
[No Abstract] [Full Text] [Related]
20. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
[No Abstract] [Full Text] [Related]
[Next] [New Search]
